Altre lingue Bio Vitos Pharma AB

Azioni

BIOVIT

SE0009320278

Mercato chiuso - Nasdaq Stockholm Altri mercati azionari 17:20:40 31/05/2024			Variaz. 5gg	Var. 1 gen.
0,133 ^SEK	-4,32%		-13,64%	-44,12%

14/02	Bio Vitos Pharma AB (publ) riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
14/02	Bio Vitos Pharma AB (publ) riporta i risultati degli utili per il quarto trimestre conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023	14/02
Bio Vitos Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	14/02
KFUM Kalmar and Bio Vitos Pharma Sign Collaboration Agreement to Conduct Research Study on Succifer	12/02
The European Patent Office EPO Grants Patent to Bio Vitos Pharma AB	20/12
Hemcheck Sweden AB will Change its Ticker to BIOVIT from HEMC	06/12
Hemcheck Sweden AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	16/11
Hemcheck Sweden AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	30/08/23
Hemcheck Sweden AB Receives A First Order from Its Distributor Astemed	15/05/23
Hemcheck Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2023	09/05/23
Hemcheck Sweden Receives New Follow Up Order from the Foundation for Innovative New Diagnostics	26/04/23
Hemcheck Sweden AB Receives First Order from the University Hospital Charité in Berlin	05/04/23
Hemcheck Sweden AB Receives First Follow Up Order from Its Finnish Distributor	13/03/23
Hemcheck Sweden AB Receives an Additional Follow-Up Order from Its Uk Distributor	02/03/23
Hemcheck Receives Follow Up Order from Research Program in the United States	28/02/23
Hemcheck Sweden AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	14/02/23
Hemcheck Sweden AB Reports Earnings Results for the Full Year Ended December 31, 2022	14/02/23
Hemcheck Sweden AB Receives Follow-Up Order from Eurobio Scientific	03/02/23
Hemcheck Sweden AB Receives Follow-Up Order from CLS	01/02/23
Hemcheck Receives First Order from Landspitali	24/01/23
Hemcheck Receives a Follow Up Order from Its Spanish Distributor	23/01/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Bio Vitos Pharma AB

Azioni

BIOVIT

SE0009320278

Altre lingue

Filtri